| Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Revenue | 11.30B | 10.86B | 9.54B | 9.89B | 8.48B |
| Cost of Revenue | 4.34B | 4.28B | 3.60B | 3.98B | 3.68B |
| Gross Profit | 6.96B | 6.58B | 5.95B | 5.91B | 4.80B |
| Operating Expenses | 4.96B | 4.75B | 4.31B | 4.31B | 3.90B |
| Selling, General & Admin | 4.29B | 4.48B | 4.09B | 4.22B | 3.60B |
| Research & Development | 311.00M | 300.00M | 257.00M | 304.00M | 292.00M |
| Other Operating Expenses | 366.00M | -31.00M | -31.00M | -212.00M | 17.00M |
| Operating Income | 2.00B | 1.82B | 1.64B | 1.60B | 897.00M |
| Other Expenses / Income | -368.00M | -207.00M | -2.00M | -7.00M | -11.00M |
| Before Tax Income | 1.63B | 1.62B | 1.64B | 1.59B | 886.00M |
| Income Tax Expenses | 517.00M | 499.00M | 197.00M | 410.00M | 199.00M |
| Net Income | 1.05B | 1.06B | 1.39B | 1.15B | 655.00M |
| Interest Expenses | 414.00M | 258.00M | 12.00M | 15.00M | 26.00M |
| Basic Shares Outstanding | 9.26B | 9.23B | 9.23B | 9.23B | 9.23B |
| Diluted Shares Outstanding | 9.26B | 9.24B | 9.23B | 9.23B | 9.23B |
| EBITDA | 2.35B | 2.18B | 2.21B | 1.91B | 1.17B |
| EBITDA Margin | 20.80% | 20.10% | 23.16% | 19.32% | 13.82% |
| EBIT | 1.98B | 1.82B | 1.60B | 1.57B | 880.00M |
| EBIT Margin | 17.52% | 16.73% | 16.75% | 15.87% | 10.38% |
| Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |